Anticonvulsant properties of linalool in glutamate-related seizure models

Phytomedicine

Volumn 6, Issue 2, 1999, Pages 107-113

  Elisabetsky, E ^a,b   Brum, L F Silva ^a   Souza, D O ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Universidade Federal do Rio ^*  (Brazil)

Author keywords

Anticonvulsants; Glutamate; Linalool; NMDA; PTZ kindling

Indexed keywords

ANTICONVULSIVE AGENT; DIZOCILPINE MALEATE; GLUTAMIC ACID; LINALOOL; N METHYLASPARTIC ACID; PENTETRAZOLE; PHENOBARBITAL; QUINOLINIC ACID; TERPENE;

ANIMAL; ARTICLE; BRAIN CORTEX; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; KINDLING; MALE; METABOLISM; RADIOASSAY; RAT; SEIZURE; WISTAR RAT;

ANIMALS; ANTICONVULSANTS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; GLUTAMIC ACID; KINDLING, NEUROLOGIC; MALE; MONOTERPENES; N-METHYLASPARTATE; PENTYLENETETRAZOLE; PHENOBARBITAL; QUINOLINIC ACID; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; SEIZURES; TERPENES;

EID: 0033126821     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0944-7113(99)80044-0     Document Type: Article

References (26)

1. Barros, D. M.: Propriedades anticonvulsivantes de linalol: interação com sistemas gabaérgico e glutamatérgico. Master's Thesis. Biochemistry Graduate Course, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 1996.
2. Barros, D. M., Elisabetsky, E.: Atividade anticonvulsivante do linalol em convulsōes induzidas por picrotoxina e estricnina. In: Annals of the XIV Simpósio de Plantas Medicinais do Brasil. Florianópolis, p. 120, EDEME, Florianópolis, Brazil, 1996.
3. Cain, D. P.: Long-term potentiation and kindling: how similar are the mechanisms. Trend Neurosci. 12: 37-43, 1989.
4. Czuczwar, S. J., Frey, H H., Loscher, W.: Antagonism of N-Methyl-D,L-aspartic acid-induced convulsions by antiepileptic drugs and other agents. Eur. J. Pharmacol. 108: 273-280, 1985.
5. Dichter, M. A., Brodie, M. J.: New antiepileptic drugs. N. Engl. J. Med. 334(24): 1583-1590, 1996.
6. Elisabetsky, E., Setzer, R.: Caboclo concepts of disease, diagnosis and therapy: implications for ethnopharmacology and health systems in Amazonia. In: The Amazon Caboclo: historical and contemporary perspectives. Ed. E. P. Parker, Williamsburg: Studies on Third World Societies Publication Series, Vol. 32, 243-278, 1985.
7. Elisabetsky, E., Marschner, J., Souza, D. O.: Effects of linalool of glutamatergic system in the rat cerebral cortex. Neurochem. Res. 20: 461-465, 1995a.
8. Elisabetsky, E., Souza, G. P. C., Santos, M. A. C., Siqueira, I. R., Amador, T. A.: Sedative properties of Linalool. Fitoterapia 115(5): 407-414, 1995b.
9. Giorgi, O., Orlandi, M., Geic, M., Corda, M. G.: MK-801 prevents the decrease in 35S-TBPS binding in the rat cerebral cortex induced by pentylenetetrazol kindling. Brain Res. Bull. 27: 835-837, 1991.
10. Hallak, M., Irtenkauf, S. M., Janusz, C. A.: Stimulation and inhibition of N-Methyl-D-aspartate receptors in rats: Developing a seizure model. Am. J. Obstet. Gynecol. 169: 695 -700, 1993.
11. Izquierdo, I., Da Cunha, C., Rosat, R., Jerusalinsky, D., Ferreira, M. B. C., Medina, J. H.: Neurotransmitter receptors involving memory processing by the amygdala, medium septum and hippocampus of rats. Behavioral and Neural Biology. 58: 16-26, 1992.
12. Kainer, K. A., Duriea, M. L.: Tapping women's knowledge: Plant resource use in extractive reserves, Acre, Brazil. Economic Botany. 46(4): 408-425, 1992.
13. Kozikowski, A. P.: Drug design for neuroscience. New York: Raven Press, 1993.
14. Lipton, S. A., Rosemberg, P. A.: Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330(9): 613-622, 1994.
15. Lowry, O. H., Rosembrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
16. Meldrum, B. S.: Excitatory amino acids in epilepsy and potential novel therapies. Epilepsy Res. 12: 189-196, 1992.
17. Meldrum, B. S.: Current strategies for designing and identifying new antieplieptic drugs. In: Epilepsy: A comprehensive textbook. Ed. J. Engler Jr. and T. A. Predley, Vol. 2, Cap. 131, Lippincott Raven, New York, 1997.
18. Meldrum, B. S.: Update on the mechanism of action of antiepileptic drugs. Epilepsia. 37 (Suppl 6): 4-11, 1996.
19. Meldrum, B. S., Garthwaite, J.: Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11: 379, 1990.
20. Obrenovitch, T. P., Urenjak, J., Zilkha, E.: Evidence disputing the link between seizure activity and high extracellular glutamate. J. Neurochem. 66(6): 2446-2454, 1996.
21. 3H]glutamate binding and on adenylate cyclase activity in rat brain membranes. Neurochem. Res. 22(2): 181-187, 1997.
22. Schröder, H., Becker, A., Lössner, B.: Glutamate binding to brain membranes is increased in pentylenetetrazole-kindled rats. J. Neurochem. 60(3): 1007-1011, 1993.
23. Silva, L. F., Pereira, P., Elisabetsky, E.: Neurochemical analysis of pentylenetetrazol-kindling in mice. Gen. Pharmacol. 30(5): in press, 1998.
24. Thomas, R. J.: Excitatory amino acids in health and disease. J. American Geriat. Soc. 43: 1279-1289, 1995.
25. White, H. S.: Clinical significance of animal seizure models and mechanisms of action studies of potential antiepileptic drugs. Epilepsia. 38 (Suppl 1): 9-17, 1997.
26. Wu, K., Wasterlain, C., Sacks, L., Siekewitz, P.: Effects of septal kindling on glutamate binding and calcium/calmodulin-dependent phospholylation in a postsynaptic density fraction isolated from rat cerebral cortex. Proc. Natl. Acad. Sci. USA. 87: 5298-5302, 1990.